Your browser doesn't support javascript.
loading
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Marconato, Maddalena; Abela, Irene A; Hauser, Anthony; Schwarzmüller, Magdalena; Katzensteiner, Rheliana; Braun, Dominique L; Epp, Selina; Audigé, Annette; Weber, Jacqueline; Rusert, Peter; Schindler, Eméry; Pasin, Chloé; West, Emily; Böni, Jürg; Kufner, Verena; Huber, Michael; Zaheri, Maryam; Schmutz, Stefan; Frey, Beat M; Kouyos, Roger D; Günthard, Huldrych F; Manz, Markus G; Trkola, Alexandra.
Afiliación
  • Marconato M; Department of Medical Oncology and Haematology; University Hospital Zurich and University of Zurich; Comprehensive Cancer Center Zurich; Switzerland.
  • Abela IA; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Hauser A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Schwarzmüller M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Katzensteiner R; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Braun DL; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Epp S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Audigé A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Weber J; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Rusert P; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Schindler E; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Pasin C; Blood Transfusion Service Zurich, Swiss Red Cross, Zurich, Switzerland.
  • West E; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Böni J; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Kufner V; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Huber M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Zaheri M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Schmutz S; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Frey BM; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Kouyos RD; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Günthard HF; Blood Transfusion Service Zurich, Swiss Red Cross, Zurich, Switzerland.
  • Manz MG; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Trkola A; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
J Clin Invest ; 132(12)2022 06 15.
Article en En | MEDLINE | ID: mdl-35482408
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article